Skip to main navigation Skip to search Skip to main content

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis

  • A Andriulli
  • , G Leandro
  • , Giovanna Niro
  • , A Mangia
  • , Valeria Festa
  • , Giovanni Gambassi
  • , Maria Roaria Villani
  • , D Facciorusso
  • , P Conoscitore
  • , F Spirito
  • , G De Maio

Research output: Contribution to journalArticle

172   Link opens in a new tab Citations (SciVal)

Abstract

The identification of therapeutic agents that can prevent the pancreatic injury after endoscopic retrograde cholangiopancreatography (ERCP) is of considerable importance.
Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalGastrointestinal Endoscopy
Volume51
Publication statusPublished - 2000

Keywords

  • Acute Disease
  • Amylases
  • Cholangiopancreatography, Endoscopic Retrograde
  • Gabexate
  • Hormones
  • Humans
  • Octreotide
  • Pain
  • Pancreas
  • Pancreatitis
  • Serine Proteinase Inhibitors
  • Somatostatin
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis'. Together they form a unique fingerprint.

Cite this